Skip to Main Content

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and the like has, predictably, returned. To cope, we are quaffing several needed cups of stimulation. Our choice so far today is the flavorful vanilla cinnamon nut. As always, please feel free to join us and, remember, no prescription is required. So there is no need to bother with co-pays or wondering about rebates. Meanwhile, here are some tidbits. Hope your day is smashing and do stay in touch …

The pharmaceutical industry, pilloried by President Trump for the last two years, is war-gaming for the possibility that its worst fear is realized: that Democrats, if they flip control of the House, find common ground with the president to rein in drug prices, The New York Times writes. Democrats say they are determined to squeeze industry prices and profits, and they have a stack of legislative proposals to do so, while drug makers are quietly making contingency plans.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!